1. Home
  2. AMWD vs FLGT Comparison

AMWD vs FLGT Comparison

Compare AMWD & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Woodmark Corporation

AMWD

American Woodmark Corporation

HOLD

Current Price

$55.36

Market Cap

803.2M

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$28.30

Market Cap

697.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWD
FLGT
Founded
1980
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Forest Products
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
803.2M
697.3M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
AMWD
FLGT
Price
$55.36
$28.30
Analyst Decision
Buy
Buy
Analyst Count
3
3
Target Price
$64.50
$28.33
AVG Volume (30 Days)
244.9K
398.3K
Earning Date
11-25-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.25
N/A
Revenue
$1,595,658,000.00
$315,549,000.00
Revenue This Year
N/A
$16.84
Revenue Next Year
$2.63
$9.74
P/E Ratio
$13.22
N/A
Revenue Growth
N/A
13.61
52 Week Low
$47.15
$14.57
52 Week High
$92.44
$31.04

Technical Indicators

Market Signals
Indicator
AMWD
FLGT
Relative Strength Index (RSI) 49.59 56.08
Support Level $53.01 $28.04
Resistance Level $57.67 $31.04
Average True Range (ATR) 2.26 0.95
MACD 1.06 -0.32
Stochastic Oscillator 82.83 22.16

Price Performance

Historical Comparison
AMWD
FLGT

About AMWD American Woodmark Corporation

American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: